April 30, 2025
We’re excited to share that our latest article “Novel microfluidic device for factor VIII quantification by chemiluminescence in hemophilia A patients” is now out in Biosensors & Bioelectronics!
In this study, we present a novel capillary-based microfluidic platform (EnzySystem) with integrated optical sensors capable of 16 simultaneous chemiluminescent measurements, designed for adaptable point-of-care diagnostics. As a proof-of-principle, a sensitive FVIII assay (FVIIIlum) for Hemophilia A management was developed, demonstrating accurate quantification of FVIII activity.
🔗 Read the full article here.
Enzyre is always looking for collaborations to expand use of its platform technologies. Interested parties are encouraged to contact us at info@enzyre.com.
Get involved